Xiyang Zhang Selected Research

Xiyang Zhang Research Topics

Disease

5	Neoplasms (Cancer) 02/2022 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 01/2015
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2019
2	Ischemia 07/2017 - 06/2017
2	Cognitive Dysfunction 06/2017 - 01/2015
2	Breast Neoplasms (Breast Cancer) 12/2016 - 08/2016
2	Osteonecrosis (Kienbock's Disease) 10/2016 - 09/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2015 - 07/2014
1	COVID-19 02/2022
1	Ileus 01/2022
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2021
1	Infections 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2019
1	Wounds and Injuries (Trauma) 12/2018
1	Parasitic Diseases (Parasitic Disease) 12/2018
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Hemorrhage 07/2017
1	Edema (Dropsy) 07/2017
1	Reperfusion Injury 06/2017
1	Diabetes Mellitus 01/2017
1	Myocardial Infarction 11/2015
1	Postoperative Cognitive Complications 01/2015
1	Stroke (Strokes) 01/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
3	VaccinesIBA 02/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020 - 08/2019
2	Caspase 3 (Caspase-3)IBA 08/2019 - 01/2015
2	DDTIBA 08/2019 - 12/2018
2	salicylhydroxamic acid (SHAM)IBA 07/2017 - 06/2017
2	Ribonucleases (Ribonuclease)IBA 06/2017 - 01/2015
2	CytokinesIBA 06/2017 - 01/2015
2	SteroidsIBA 10/2016 - 09/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 07/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2022
1	Monoclonal AntibodiesIBA 02/2022
1	6-methyladenineIBA 01/2022
1	Fatty Acid-Binding ProteinsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 09/2020
1	Cysteine (L-Cysteine)FDA Link 09/2020
1	Lysophosphatidic Acid ReceptorsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	AntigensIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Hepatocyte Nuclear FactorsIBA 01/2020
1	Peptides (Polypeptides)IBA 08/2019
1	Cyclin D1IBA 08/2019
1	Caspase 8 (Caspase-8)IBA 08/2019
1	Adenosine Triphosphate (ATP)IBA 08/2019
1	Caspase 9IBA 08/2019
1	Cytochromes c (Cytochrome c)IBA 08/2019
1	Cyclin B1IBA 08/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2019
1	Interleukin-6 (Interleukin 6)IBA 03/2019
1	LipidsIBA 03/2019
1	Palmitic Acid (Hexadecanoic Acid)IBA 03/2019
1	Mitotane (Lysodren)FDA Link 12/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2018
1	Dichlorodiphenyldichloroethane (DDD)IBA 12/2018
1	cariporideIBA 07/2017
1	Sodium Channels (Sodium Channel)IBA 07/2017
1	p38 Mitogen-Activated Protein KinasesIBA 07/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	AcylphosphataseIBA 12/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2016
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2015
1	Neuroprotective AgentsIBA 01/2015

Therapy/Procedure

6	Therapeutics 02/2022 - 07/2014
1	Drug Therapy (Chemotherapy) 02/2022
1	Length of Stay 01/2022
1	Nephrectomy 01/2015